You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDL1

Showing 101 - 125 of 745
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Primary Amyloidosis Trial in United States (drug, biological, other)

Active, not recruiting
  • Recurrent Primary Amyloidosis
  • Duarte, California
  • +4 more
Mar 10, 2021

Melanoma, Non Small Cell Lung Cancer Trial in Siena (Ipilimumab plus nivolumab plus guadecitabine, Ipilimumab plus nivolumab)

Not yet recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Ipilimumab plus nivolumab plus guadecitabine
  • Ipilimumab plus nivolumab
  • Siena, Italy
    Center for Immuno-Oncology, University Hospital of Siena
Jan 29, 2020

Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

Recruiting
  • Digestive System Cancers
  • Beijing, China
    Peking University Cancer Hospital
Oct 25, 2023

Efficiency and Safety of ICIs in Different Malignancies

Recruiting
  • Melanoma
  • +3 more
  • Genetic tests of the available tumor and plasma samples
  • Moscow', Москва, Russian Federation
    N.N. Blokhin Russian Cancer Research Center
Dec 26, 2021

Radiomics for prEdiction of lunG cAncer biologY

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • PET/CT
  • Poitiers, France
    CHU Poitiers
Apr 5, 2023

Metastatic Non Small Cell Lung Cancer Trial in Singapore (Nivolumab, ADG106)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Singapore, Singapore
  • +1 more
Mar 10, 2022

Metastatic Colorectal Cancer, Triple Negative Breast Cancer, Prostate Adenocarcinoma Trial in Villejuif (Tremelimumab,

Active, not recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jun 7, 2019

Registry Study in MSI/dMMR Solid Tumors

Not yet recruiting
  • DMMR Cancer
  • +2 more
    • (no location specified)
    Aug 21, 2023

    NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • London, United Kingdom
      Univeristy College London Hospital
    Feb 22, 2022

    Advanced Solid Tumor Trial in Bordeaux (MEDI5752)

    Not yet recruiting
    • Advanced Solid Tumor
    • Bordeaux, France
      Institut Bergonie
    May 24, 2023

    Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

    Not yet recruiting
    • Pancreatic Cancer
    • Baltimore, Maryland
      SKCCC Johns Hopkins
    Aug 16, 2023

    Urothelial Carcinoma Trial in United States (Carboplatin, Gemcitabine, Atezolizumab)

    Active, not recruiting
    • Urothelial Carcinoma
    • Indianapolis, Indiana
    • +3 more
    Feb 14, 2022

    Lung Cancer Trial in Angers, St Herblain (Metastasis biopsy)

    Not yet recruiting
    • Lung Cancer
    • Metastasis biopsy
    • Angers, France
    • +1 more
    Jul 26, 2022

    Advanced Solid Tumors Trial in Worldwide (Quavonlimab, Pembrolizumab, Pembrolizumab/Quavonlimab)

    Active, not recruiting
    • Advanced Solid Tumors
    • Quavonlimab
    • +2 more
    • Gilbert, Arizona
    • +52 more
    Aug 18, 2022

    Gut Microbiome in Anti-tumor Therapy Induced Diarrhea

    Recruiting
    • Cancer
      • Graz, Austria
        Department of Internal Medicine, Medical University of Graz
      May 15, 2023

      Safety of ICIs and TKIs Therapy for HCC

      Recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • Lenvatinib Oral Product
      • +2 more
      • Wuhan, Hubei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      Jun 11, 2022

      Squamous Cell Carcinoma Trial (MK-3475A)

      Not yet recruiting
      • Squamous Cell Carcinoma
      • MK-3475A
      • (no location specified)
      Sep 11, 2023

      Baseline Metastases on Clinical Outcomes Among BRAF Positive

      Completed
      • BRAF Positive Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis
        Aug 2, 2023

        Glioblastoma Trial in Roma (Blood sample)

        Recruiting
        • Glioblastoma
        • Blood sample
        • Roma, Italy
          Fondazione Policlinico Universitaro "A. Gemelli" IRCCS
        Mar 29, 2023

        Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,

        Active, not recruiting
        • Lung Non-Small Cell Carcinoma
        • +9 more
        • Atlanta, Georgia
          Emory University Hospital/Winship Cancer Institute
        Aug 22, 2022

        Hodgkin Lymphoma Trial in France (blood samples)

        Active, not recruiting
        • Hodgkin Lymphoma
        • blood samples
        • Angers, France
        • +21 more
        Oct 27, 2022

        Advanced Tumors Trial in Jinan, Shanghai (PM1022)

        Recruiting
        • Advanced Tumors
        • Jinan, Shandong, China
        • +1 more
        May 10, 2023

        Triple-Negative Breast Cancer Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody, Atezolizumab

        Active, not recruiting
        Has Results
        • Triple-Negative Breast Cancer
        • Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody
        • +2 more
        • Stanford, California
        • +160 more
        Oct 26, 2022

        Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Durvalumab, Rituximab, Doxorubicin)

        Completed
        Has Results
        • Lymphoma, Large B-Cell, Diffuse
        • Gilbert, Arizona
        • +18 more
        Aug 19, 2022

        Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis Trial in Chicago (Durvalumab, Laboratory

        Withdrawn
        • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
        • Primary Myelofibrosis
        • Durvalumab
        • Laboratory Biomarker Analysis
        • Chicago, Illinois
          Northwestern University
        Aug 16, 2019